Bioartificial organ systems are becoming more attractive options for end-stage organ disease. Currently, end-stage liver disease has several palliative options but relies on transplantation for curative management. A new bioartificial liver has been approved for clinical trials in China and helps support the failed liver via stem cells.
© 2023 International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.